These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 32466856)
1. The MiR-17-92 Gene Cluster is a Blood-Based Marker for Cancer Detection in Non-Small-Cell Lung Cancer. Yang C; Jia X; Zhou J; Sun Q; Ma Z Am J Med Sci; 2020 Sep; 360(3):248-260. PubMed ID: 32466856 [TBL] [Abstract][Full Text] [Related]
2. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
3. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010 [TBL] [Abstract][Full Text] [Related]
4. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients. Zhang Y; Zhang Y; Yin Y; Li S Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974 [TBL] [Abstract][Full Text] [Related]
5. High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer. Xu X; Zhu S; Tao Z; Ye S Cancer Med; 2018 Jan; 7(1):21-31. PubMed ID: 29266846 [TBL] [Abstract][Full Text] [Related]
6. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
7. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer. Shi GL; Chen Y; Sun Y; Yin YJ; Song CX Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492 [TBL] [Abstract][Full Text] [Related]
8. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
9. Potential circulating miRNA signature for early detection of NSCLC. Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589 [TBL] [Abstract][Full Text] [Related]
10. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer. Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397 [No Abstract] [Full Text] [Related]
11. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients. Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Serum Paired MicroRNA Ratios for Differential Diagnosis of Non-Small Cell Lung Cancer and Benign Pulmonary Diseases. Fan L; Sha J; Teng J; Li D; Wang C; Xia Q; Chen H; Su B; Qi H Mol Diagn Ther; 2018 Aug; 22(4):493-502. PubMed ID: 29922886 [TBL] [Abstract][Full Text] [Related]
13. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer. Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307 [TBL] [Abstract][Full Text] [Related]
14. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer. Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320 [TBL] [Abstract][Full Text] [Related]
15. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer. Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767 [TBL] [Abstract][Full Text] [Related]
17. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer. Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897 [TBL] [Abstract][Full Text] [Related]
18. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers. Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400 [TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108 [TBL] [Abstract][Full Text] [Related]
20. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. Ulivi P; Foschi G; Mengozzi M; Scarpi E; Silvestrini R; Amadori D; Zoli W Int J Mol Sci; 2013 May; 14(5):10332-42. PubMed ID: 23681013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]